Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Comparison of Hormonal vs Mechanical Contraception for Reduction of Trophoblastic Sequelae Following Hydatidiform Mole
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
NCI
GOG-55
2.
Phase III Randomized Trial of Hormone Therapy with TMX vs MEG vs TMX plus MEG in Patients with Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NEDH-D-83007
NCI-V85-0130
Last Modified:
7/30/2008
 
First Published:
4/1/2002
3.
Phase II Randomized Study of Medroxyprogesterone Versus Ethinyl Estradiol and Norgestrel For the Prevention of Endometrial Carcinogenesis in Women With a Known Hereditary Non-Polyposis Colon Cancer (HNPCC)-Associated Gene Mutation or HNPCC-Associated Cancer(s)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Closed
25 to 50
NCI
MDA-ID-01340
TX035, NCI-P02-0218, N01-CN-05127, NCT00033358
4.
Phase II Sequential Treatment with Ethinyl Estradiol and MPA for Metastatic and/or Recurrent Breast Cancer in Postmenopausal Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
75 and under
PCCC-83239
NCI-V83-0354
5.
Phase II Evaluation of the Effect of Estrogenic Recruitment on Response to FAC Combination Chemotherapy for Advanced Stage III/IV Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 71
EORTC-10807
6.
Phase II Hormone Manipulation Therapy with Ethinyl Estradiol and MPA for Recurrent Epithelial Ovarian Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
45 and over
MDA-G-8006
NCI-V84-0022
Last Modified:
8/1/1991
7.
Phase II Study of CALF-E (CTX/ADR/CF/5-FU/Ethinyl Estradiol) Induction and Radiotherapy in Patients with Breast Cancer Stages III and IV, Clinical T3N0, and Stage II with Four or More Positive Nodes (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
GUMC-7589
NCI-V89-0179
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute